Summary
The Mediterranean osteoporosis study (MEDOS) questionnaire was designed by a group of specialists in bone disease from Southern Europe (MAB Group) and the WHO Collaborating Centre for the Epidemiology of Rheumatic Conditions, assisted by experts from WHO in Geneva and from the European Foundation for Osteoporosis and Bone Disease. The purpose of the questionnaire was to identify putative risk factors for hip fracture in a retrospective case control study applied during a prospective study of the incidence of hip fracture in 14 regions of Europe.
Similar content being viewed by others
Reference
J. Dequeker, L. Tobing, V. Rutten, P. Geusens, and MEDOS Study Group: Relative risk factors for osteoporotic fracture: a validation of the MEDOS questionnaire. Clin Rheumatol, 1991, 10, 1, 49–53.
Author information
Authors and Affiliations
Consortia
Additional information
Collaborating Centers: Dilşen, G., Istanbul; Gennari, C., Siena; Lopez Vaz, A.A., Porto; Lyritis, G., Athens; Mazzuoli, G.D. Rome; Miravet, L., Paris; Passeri, M., Parma; Perez Cano, R., Sevilla; Rapado, A., Madrid; Ribot, C., Toulouse.
Project Group: Allander, E., WHO Collaborating Centre for the Epidemiology of Rheumatic Conditions, Huddinge; Dequeker, J., WHO Consultant, Leuven; Gonzalez, A., Sandoz Basle; Kanis, J.A., European Osteoporosis Foundation, Sheffield; Keen, D., Sandoz Basle; Khaltaev, N., WHO Non-communicable Diseases, Geneva; Plüss M., Sandoz Basle.
Copyright of the European Foundation for Osteoporosis and Bone Disease.
Rights and permissions
About this article
Cite this article
Dequeker, J., Ranstam, J., Valsson, J. et al. The Mediterranean osteoporosis (MEDOS) study questionnaire. Clin Rheumatol 10, 54–72 (1991). https://doi.org/10.1007/BF02208034
Issue Date:
DOI: https://doi.org/10.1007/BF02208034